Literature DB >> 1890954

The low-Ca2+ response virulence regulon of human-pathogenic Yersiniae.

S C Straley1.   

Abstract

The Lcr is thought to function when the yersiniae infect their mammalian host (see Fig. 2). At present, all evidence points to roles of the Lcr in protecting the bacteria in extracellular niches. We can speculate that early in infection, the yersiniae experience a 37 degrees C extracellular, Ca(2+)-containing environment. Temperature-induction and down-modulation by Ca2+ would occur for Lcr genes, resulting in a cytotoxic and weakly anti-phagocytic surface on the bacteria. Yersiniae that are taken up into macrophages may find a low-Ca2+, inductive environment for expression and release of Yops and V antigen. Upon release from macrophages, the accumulated Yops may render the bacteria sufficiently anti-phagocytic to resist ingestion by neutrophils, and Lcr virulence proteins such as YopM, and perhaps V antigen and other Yops might act to dampen the inflammatory response and prevent secondary influxes of phagocytes. The abundant nucleotides from necrotic host cells undergoing nucleic acid breakdown might then promote extracellular growth. Even though Lcr virulence genes would be expressed at an intermediate level under these conditions, this may be sufficient for the continued undermining of the host natural defenses. It also is possible that there are additional environmental signals, not yet identified, that modulate Lcr virulence gene expression and permit strong expression in extracellular microenvironments that arise as a result of the host-yersiniae interactions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1890954     DOI: 10.1016/0882-4010(91)90069-m

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  17 in total

1.  Structure and regulation of the Yersinia pestis yscBCDEF operon.

Authors:  P L Haddix; S C Straley
Journal:  J Bacteriol       Date:  1992-07       Impact factor: 3.490

Review 2.  Yersinia enterocolitica: the charisma continues.

Authors:  E J Bottone
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

3.  Maximizing plasmid stability and production of released proteins in Yersinia enterocolitica.

Authors:  H Li; S Bhaduri; W E Magee
Journal:  Appl Environ Microbiol       Date:  1998-05       Impact factor: 4.792

4.  PCR detection of virulence genes in Yersinia enterocolitica and Yersinia pseudotuberculosis and investigation of virulence gene distribution.

Authors:  P Thoerner; C I Bin Kingombe; K Bögli-Stuber; B Bissig-Choisat; T M Wassenaar; J Frey; T Jemmi
Journal:  Appl Environ Microbiol       Date:  2003-03       Impact factor: 4.792

Review 5.  Yops of Yersinia spp. pathogenic for humans.

Authors:  S C Straley; E Skrzypek; G V Plano; J B Bliska
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

6.  Identification and molecular characterization of a Salmonella typhimurium gene involved in triggering the internalization of salmonellae into cultured epithelial cells.

Authors:  C Ginocchio; J Pace; J E Galán
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

7.  The Yersinia pseudotuberculosis adhesin YadA mediates intimate bacterial attachment to and entry into HEp-2 cells.

Authors:  J B Bliska; M C Copass; S Falkow
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

8.  Plasmid regulation and temperature-sensitive behavior of the Yersinia pestis penicillin-binding proteins.

Authors:  R C Ferreira; J T Park; L C Ferreira
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

9.  Complete DNA sequence and detailed analysis of the Yersinia pestis KIM5 plasmid encoding murine toxin and capsular antigen.

Authors:  L E Lindler; G V Plano; V Burland; G F Mayhew; F R Blattner
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  Immunization with live recombinant Salmonella typhimurium aroA producing F1 antigen protects against plague.

Authors:  P C Oyston; E D Williamson; S E Leary; S M Eley; K F Griffin; R W Titball
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.